Talk:Christoph Huber

Work on this page in progress

Bamyers99

I created this page and am working to find better sources and refine the text to meet wiki criteria. I do not have a COI for Huber but a passing interest in his invention. Perhaps I could request a review of the material in a few days? Thank you in advance, KHBibby (talk) 22:41, 9 March 2016 (UTC)

Jytdog why is my name listed in the banner above as a potential COI? This is not true at all as we discussed you said it wasn't a problem (I have been slowly building a better page for this after reviewing other wiki pages in this field). Can you help me? Thank-you,KHBibby (talk) 06:04, 16 April 2016 (UTC)

fixed. thx Jytdog (talk) 07:26, 16 April 2016 (UTC)

Thank-you! KHBibby (talk) 23:10, 16 April 2016 (UTC)

unsourced content part 1

The following is unsourced and cannot be in a WP:BLP article

Christoph Huber's formative years were spent in Liestal, Switzerland. After graduation he enrolled in medicine at the Basel University and obtained his medical degree (MD) in 1998. Huber later acquired a Dr. med. of Human Science, served as an Army doctor and acquired a ECFMG/USMLE degree (Geneva, Switzerland and London, UK). Huber completed his General Surgery Residency in 2001 at the Department of General Vascular and Thoracic Surgery, District Hospital of Biel and in 2002 his Cardiovascular Residency at the University Clinic Hospital Bern/Inselspital. From 2002-07, Huber worked as a cardiovascular surgeon (and Chief Resident Surgeon) at the University Hospital Lausanne and Senior Cardiac surgical clinical fellowship at Brigham and Women's Hospital, Boston, USA (2004–05). In 2007 he passed the Swiss National Board of Cardiovascular surgery (FMH) while in Adult Cardiac Surgery at the Heart Center Valais, RSV, Sion and University Hospital Lausanne. Huber’s work was recognized with five notable awards (refer below), and in February 2007 awarded a six year Swiss National Research Grant to develop “Direct Access Valve Replacement (DAVR) for aortic valves via the Trans Apical Procedure (TAP)” in Bern. In 2008-09, Huber received certification as a full medical practitioner, specializing in cardiothoracic surgery at the Great Ormond Street Hospital, London, UK. The same year, Huber’s “Direct access aortic valve replacement” research was recognized with a Center for Cardiovascular and Metabolic Research grant. In 2009, he published the first text book on aortic transcatheter valve therapies (refer 'Publications' below). Since 2010, Huber has worked a the Clinic for Cardiovascular Surgery, University Hospital Bern/Inselspital as the Senior Consultant of the Cardiovascular Surgery Division, Director of the Surgical TAVI Program, Director of skills training for medical students and as a cardiovascular lecturer. In 2012, he acquired a Privat Dozent (Priv.Doz) degree. Huber performs the majority of all transapical TAVI cases at Bern. Huber also dedicates many hours to Science and Technology Studies (EDGE) in Switzerland, Stiftung HeartLAB International and Advanced Trauma Life Support (ATLS).

- Jytdog (talk) 08:49, 18 February 2016 (UTC)

unsourced/inappropriately sourced content 2, also promotional

The following needs review for NPOV and sourcing before it is added to a live WP article on an LP

As a cardiac surgeon, Huber witnessed the negative aspects of heart surgery on severely sick patients, including the high rate of complications, the need to split the chest in order to gain heart access ,and use of heart lung machines. He began to delve further into new aortic valve replacement strategies, and by 2004, pioneered the first “Acurate TA valve” for use in “transapical transcatheter aortic valve implantations” (TAVI). The device received two boosts in 2005: by the FDA’s choice to revoke “transseptal access” (and the voluntary withdrawl of Edwards Lifesciences) and through a research publication by major American cardiology specialists describing Huber’s transapical technique as “one of the most promising treatment modalities to modernized minimally invasive cardiac surgery.” In 2006, Huber’s “Acurate TA-TAVI” method was performed for the first time by Dr. Thomas Walter.

The TA device is described as "self-seating and self-sealing" and composed of a “porcine tissue valve sewn within a self-expanding nitinol stent covered by an anti-PV leak skirt designed for transapical implantation...[and] approach uses a “two-step implantation procedure with ventricular unsheathing [which] provides simple positioning and tactile feedback during implant.” Huber’s TA-TAVI device received CE approval in September 2011 and patent registered in May 2012 (US8182530B2). TA-TAVI is an established, minimally invasive aortic valve replacement procedure in high-risk and elderly patients (with severe calcific aortic stenosis and at high or prohibitive surgical risk). Huber’s self-expanding stent also improves paravalvular leakage and other related complications not addressed by older first generation TAVI devices, such as, Edwards Lifesciences Sapien’s “balloon-expandable” valve (and 3’s “self-sealing cuff” device), and Medtronic’s “CoreValve” device.

References

-Jytdog (talk) 08:51, 18 February 2016 (UTC)

unsourced/inappropriately content 3 - content making health claims, not sourced to WP:MEDRS and promotional

A study conducted 2011-2013, however, described Huber’s self-expanding device as having only comparable attributes (and not superior) over Sapien’s balloon device. Huber and other researchers have countered the superiority of the device, including it being ‘the only antegrade routed TAVI’ approach…[which lowers] the risk of stroke and complications from 10% to 1%.’ Data also indicates its “short and antegrade approach allows for a precise device delivery…[and] might also be the most versatile TAVI access for other interventions in structural heart disease and specially well suited to access the heart for transcatheter mitral valve repair and replacement.” The device had 21% market share (second place) of the transapical segment of the European TAVI market in September 2015.’

Since 2011, Huber’s TA innovation was the “third most frequently implanted TA-TAVI device, with over 1200 implants in Europe and South America, and a procedural success rate of 98.0%.’ In 2014 test results indicated Huber’s device showed “a safety and efficacy profile comparable, if not improved in some aspects, to earlier approved TAVI valves. The device's ease-of-use is illustrated by the negligible learning curve as seen in the high procedure success rate...[and] functional outcome with 97.5% of patients without relevant leak[age].”

Hubert continues to conduct cardiovascular research, including recent collaborative efforts into battery-less (sunlight and cardiacmotion) powered pacemakers and aortic valve flow simulation.

References

- Jytdog (talk) 08:53, 18 February 2016 (UTC)

unsourced content 4 with inappropriate embedded ELs

Awards and honors

• Sept. 2014 - Swiss SIWF Award: Distinction as best (cardiac surgery) Swiss teacher for Cardiac Surgery - Bern, Switzerland
• Oct. 2012 - PCR London Valves Best Case Award: Worldwide first surgical implantation of a transcatheter valved stent in micral position - London, UK
• May 2009 - National Research Prize, Swiss Heart Foundation: In recognition for development of the transapical TAVI approach (Trans Catheter Valve Replacement of the Aortic Valve - The Direct Access Trans Apical Procedure)
• Sept. 2007 - Techno College Innovation Award: In recognition for development of the transapical TAVI approach (The Trans Apical Procedure for the Direct Access Aortic Valve Replacement/DAVR) - European Association of Cardio-Thoracic Surgery EACTS/ESTS - 6th Joint Meeting, Geneva, Switzerland
• Sept. 2005 - St. Jude Medical, C. Walton Lillehei, PH.D, MD. Young Investigator’s Award: For presentation of ‘Direct Access Aortic Valve Replacement/DAVR – Are we entering a new era?’ - European Association of Cardio-Thoracic Surgery EACTS/ESTS - 4th Joint Meeting - Barcelona, Spain
• June 2005 – Swiss Society of Thoracic-Cardiac and Vascular Surgery Award: ‘Direct Access Percutaneous Valve Replacement - A novel approach to minimally invasive off-pump aortic valve replacement using valved stents’ - Zürich, Switzerland
• Feb. 2004 - ISES Peripheral Vascular Fellow’s Forum Award: For presentation of ‘New tools for new goals: Ultrasound navigation through the heart for off-pump aortic valved stent implantation’ - Scottsdale, Arizona, USA
• Oct. 2003 - St. Jude Medical, C. Walton Lillehei, PhDl, MD. Young Investigator’s Award (First Prize): For presentation ‘Do Valved Stent Compromise Coronary Flow?’ - European Association of Cardio-Thoracic Surgery EACTS/ESTS 2nd Joint Meeting - Vienna, Austria

- Jytdog (talk) 08:55, 18 February 2016 (UTC)

unsourced part 5 - not fully formatted so not verifiable

Publications

Books and chapters:

• Transcatheter Valve Therapies - Huber C. (ed); Feldman, T.; Cohn, LH - 2009
• Postoperative quality of life assessment in the over 80's after cardiac surgery in Handbook of Disease Burdens and Quality of Life Measures - Huber, C.; Preedy, Victor R.; Watson, Ronald R. (ed); Springer, Heidelberg - 2009
• Atlas and training manual for the Symetis Acurate TA valve - Huber, C. - 2013
• Book Chapter (Trauma Thoracotomy)in Handbook ExACT Surgery Course - Huber, C.; Schnuriger, B. - 2016

Articles:

• 75 articles (1,082 citations) as of Sept. 2015 - refer Research Gate and Web of Science, Thomson Reuters

unsourced part 6

the following is unsourced and has inappropriate embedded ELs

Member

• Permanent delegate of Chamber of Physicians of the Swiss Medical Association (FMH representing Swiss Society of Thoracic and Cardio Vascular Surgery - 2012)
• Board member Swiss Society of Cardiac and Thoracic-Vascular Surgery (SGHC - 2012)
• Member European Association for Cardio-Thoracic Surgery (EACTS)
• Member Society of Thoracic Surgeons (STS)
• Member Association of Swiss Assistant Doctors and Chief Physicians/Consultants (VSAO)

Speaking/Chair engagements

Huber is an annual invited speaker and/or chairman at the European Association Cardio Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), as well, in Switzerland for the Swiss Society of Cardiology (SGK), Thoracic-Vascular Surgery (SGHC) and Swiss Society of Surgery (SSS/ SGC-SSC). Other engagements in Switzerland include the National Joint Year Congress, Heart Valve Symposium, General Medicine Forum, Swiss TAVI User Event and HeartLAB International. He is also an annual contributor at the PCR London Valves (UK) and EuroPCR and has presented at a number of other conferences in Europe and the USA.

- Jytdog (talk) 08:57, 18 February 2016 (UTC)

Partial EL

This EL

• "The TA Plug" - European Association for Cardio-Thoracic Surgery 2012

has only part of the article. Where is the rest of the article on Huber? Jytdog (talk) 09:11, 18 February 2016 (UTC)

Request information and COI removed

Doc James Thank-you, I did not realize ResearchGate was not an acceptable source and the ‘CV' notation is helpful to how I view the page. Could you tell me why was the text book note/reference removed? Is the reference lacking? (jytDog helped with the link initially to external references). The 'Inventor' Section is being worked on in my Sandbox. Also, I am requesting that the COI notation on me be removed on this page, the issue was discussed with jytDog extensively and flag removed. Thanks in advance,KHBibby (talk) 05:44, 20 April 2016 (UTC)

jytdog could review the above when you have time? Thank-you,KHBibby (talk) 05:44, 20 April 2016 (UTC)

Doc James - With regards to the COI, I explained my reasons for this page to user jytdog and the COI was removed (e.g. and it took me 3 months to do 5 paragraphs, so I am not sure how that appears 'COI-ish'???) Also, there are a a lot of cardiac surgeon wiki pages that are severely lacking in sources that I looked at when I first created this page (which I releazed deserved to be deleted and redone as pointed out by jytdog ). I have decided, as noted to jytdog earlier in the year, that I no longer wish to volunteer my time creating Living Person pages. I am sure wiki could use my help in other ways as i get better at learning the guidelines, Thx,KHBibby (talk) 03:16, 22 April 2016 (UTC)

The article is looking pretty good now! Yes we have a lot of problems in WP with people using it to promote themselves. I appreciate very much your efforts to edit well! Jytdog (talk) 03:33, 22 April 2016 (UTC)

Thank you jytdog, I needed this encouragement (and understand why WP would be worried about promo content so I try and watch out for that now...you taught me ALOT, and still learning).KHBibby (talk) 03:50, 22 April 2016 (UTC)

Okay sounds good. Referencing patent applications such as this http://www.google.com/patents/US8182530 is not the best source. Better to stick with secondary sources that comment on the wider picture. Doc James (talk · contribs · email) 05:25, 22 April 2016 (UTC)

OK, thank-you for feedback!KHBibby (talk) 07:12, 23 April 2016 (UTC)

Thank-you will find additional references

Jytdog Thank-you for encouragement as always, I am losing confidence in my editing abilities late and have been off wiki for a while due to my health however managed some reading on the references I had used on this page. I will find another reference to help with the 'first' wording (difficult with wording the sentence correctly) and if unable to I will take it out - will upload to tomorrow if I can find one.KHBibby (talk) 07:04, 25 May 2016 (UTC)

I removed Thomas/first in-men reference (originally inserted from a document I read but I cannot find it now, so it is not verifiable at the moment since I cannot locate another source). Thank-you for pointing this out. Will help when I have the energy to start editing for WP on other contributor pages. KHBibby (talk) 02:46, 26 May 2016 (UTC)

External links modified

Hello fellow Wikipedians,

I have just modified 2 external links on Christoph Huber. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

• Added archive https://web.archive.org/web/20160507102942/http://www.herzundgefaesse.insel.ch/de/aerzteteam/huber-christoph/ to http://www.herzundgefaesse.insel.ch/de/aerzteteam/huber-christoph/
• Added archive https://web.archive.org/web/20160426053726/http://www.swissheart.ch/index.php?id=283&no_cache=1&L=3&tx_ttnews%5Bpointer%5D=4&tx_ttnews%5Btt_news%5D=215&tx_ttnews%5BbackPid%5D=7&cHash=8fddcdcbc844100caa9d9ef9bbd53223 to http://www.swissheart.ch/index.php?id=283&no_cache=1&L=3&tx_ttnews%5Bpointer%5D=4&tx_ttnews%5Btt_news%5D=215&tx_ttnews%5BbackPid%5D=7&cHash=8fddcdcbc844100caa9d9ef9bbd53223

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 5 June 2024).

• If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
• If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 16:11, 6 August 2017 (UTC)